Super-activated interferon-regulatory factors can enhance plasmid immunization

被引:31
作者
Bramson, JL
Dayball, K
Hall, JR
Millar, JB
Miller, M
Wan, YH
Lin, RT
Hiscott, J
机构
[1] McMaster Univ, Ctr Gene Therapeut, Dept Pathol & Mol Med, Hamilton, ON L8N 3Z5, Canada
[2] McGill Univ, Mol Oncol Grp, Lady Davis Inst Med Res, Montreal, PQ H3T 1E2, Canada
[3] McGill Univ, Dept Microbiol & Immunol, Montreal, PQ H3T 1E2, Canada
基金
加拿大健康研究院;
关键词
plasmid vaccine; interferon-regulatory factor;
D O I
10.1016/S0264-410X(02)00694-1
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
We have been investigating the adjuvant properties of two super-activated interferon-regulatory factors (IRFs), IRF-3(5D) and IRF7/3A, identified in our previous studies of structure-function relationships, for enhancing plasmid vaccines. Intramuscular injection of plasmid cocktails encoding IRF-3(5D) and IRF7/3A molecules elicited cytotoxic T cell responses in over 80% of mice following a single immunization compared to a 20% response-rate using a control cocktail. Most interestingly, greater than 60% of mice immunized with the super-activated IRFs developed antigen-specific antibodies compared to 0% of the mice in the control group. Finally, vaccines which incorporated the super-activated IRFs provided greater protection against challenge with a recombinant vaccinia virus. These results support further investigation of the potential of these agents as adjuvants for genetic immunization. (C) 2002 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:1363 / 1370
页数:8
相关论文
共 23 条
[1]   Characterization of the interferon regulatory factor-7 and its potential role in the transcription activation of interferon A genes [J].
Au, WC ;
Moore, PA ;
LaFleur, DW ;
Tombal, B ;
Pitha, PM .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (44) :29210-29217
[2]   Bacterial CpG-DNA triggers activation and maturation of human CD11c-, CD123+ dendritic cells [J].
Bauer, M ;
Redecke, V ;
Ellwart, JW ;
Scherer, B ;
Kremer, JP ;
Wagner, H ;
Lipford, GB .
JOURNAL OF IMMUNOLOGY, 2001, 166 (08) :5000-5007
[3]   Enhancing immune responses using suicidal DNA vaccines [J].
Berglund, P ;
Smerdou, C ;
Fleeton, MN ;
Tubulekas, I ;
Liljeström, P .
NATURE BIOTECHNOLOGY, 1998, 16 (06) :562-565
[4]   Pre-existing immunity to adenovirus does not prevent tumor regression following intratumoral administration of a vector expressing IL-12 but inhibits virus dissemination [J].
Bramson, JL ;
Hitt, M ;
Gauldie, J ;
Graham, FL .
GENE THERAPY, 1997, 4 (10) :1069-1076
[5]   DNA vaccines: Immunology, application, and optimization [J].
Gurunathan, S ;
Klinman, DM ;
Seder, RA .
ANNUAL REVIEW OF IMMUNOLOGY, 2000, 18 :927-974
[6]   DNA immunization against herpes simplex virus: Enhanced efficacy using a Sindbis virus-based vector [J].
Hariharan, MJ ;
Driver, DA ;
Townsend, K ;
Brumm, D ;
Polo, JM ;
Belli, BA ;
Catton, DJ ;
Hsu, D ;
Mittelstaedt, D ;
McCormack, JE ;
Karavodin, L ;
Dubensky, TW ;
Chang, SMW ;
Banks, TA .
JOURNAL OF VIROLOGY, 1998, 72 (02) :950-958
[7]   The IRF-3 transcription factor mediates sendai virus-induced apoptosis [J].
Heylbroeck, C ;
Balachandran, S ;
Servant, MJ ;
DeLuca, C ;
Barber, GN ;
Lin, RT ;
Hiscott, J .
JOURNAL OF VIROLOGY, 2000, 74 (08) :3781-3792
[8]  
Iwasaki A, 1997, J IMMUNOL, V158, P4591
[9]   Primary activation of interferon A and interferon B gene transcription by interferon regulatory factor 3 [J].
Juang, YT ;
Lowther, W ;
Kellum, M ;
Au, WC ;
Lin, R ;
Hiscott, J ;
Pitha, PM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (17) :9837-9842
[10]  
Klinman DM, 1997, J IMMUNOL, V158, P3635